Stock VICORE PHARMA HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Vicore Pharma Holding AB Nasdaq Stockholm

Equities

Biotechnology & Medical Research

End-of-day quote Nasdaq Stockholm
Other stock markets
- SEK - Intraday chart for Vicore Pharma Holding AB
07/05 Vicore Pharma Holding AB Announces Board Appointments CI
03/05 Vicore Pharma Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Vicore Pharma Holding AB is a Sweden-based drug-development company. The Company's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The Company is a wholly owned subsidiary of Mintage Scientific AB.

Managers

Managers TitleAgeSince
Ahmed Mousa CEO
 Chief Executive Officer 40 09/23/09
Hans Jeppsson DFI
 Director of Finance/CFO - 01/17/01
Elin Rosendahl CTO
 Chief Tech/Sci/R&D Officer - 16/20/16
Nina Carlén ADM
 Chief Administrative Officer - 01/09/01
Bertil Lindmark CTO
 Chief Tech/Sci/R&D Officer 68 01/01
Johan Raud CTO
 Chief Tech/Sci/R&D Officer - 01/18/01
Mikael Nygård PRN
 Corporate Officer/Principal - -
Åsa Magnusson PRN
 Corporate Officer/Principal - -
Jessica Shull PRN
 Corporate Officer/Principal - 01/21/01
Johanna Gräns PRN
 Corporate Officer/Principal - 01/15/01

Members of the board

Members of the board TitleAgeSince
Jacob Uno Stanley Gunterberg BRD
 Director/Board Member 57 01/18/01
Johannes G. C. P. Schikan CHM
 Chairman 66 01/18/01
Michael Buschle BRD
 Director/Board Member 64 01/23/01
Heidi Hunter BRD
 Director/Board Member 66 01/20/01
Margareta Elisabeth Björk BRD
 Director/Board Member 63 01/23/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 111,722,979 96,099,394 ( 86.02 %) 0 86.02 %

Shareholders

NameEquities%Valuation
HealthCap AB
16.49 %
18,427,774 16.49 % 30 M kr
Fjärde AP-fonden
9.810 %
10,960,399 9.810 % 18 M kr
HBM Partners AG (Investment Management)
9.734 %
10,874,727 9.734 % 18 M kr
Hans Bo Göran Wessman
3.590 %
4,010,340 3.590 % 7 M kr
Unionen
3.386 %
3,782,539 3.386 % 6 M kr
C Worldwide Asset Management Fondsmæglerselskab A/S (Sweden)
2.998 %
3,350,000 2.998 % 6 M kr
Tredje AP-fonden
2.745 %
3,066,425 2.745 % 5 M kr
Jesper Lyckeus
2.414 %
2,697,000 2.414 % 4 M kr
Swedbank Robur Fonder AB
2.155 %
2,407,163 2.155 % 4 M kr
The Invus Group LLC
1.994 %
2,227,200 1.994 % 4 M kr

Company contact information

Vicore Pharma Holding AB

Kornhamnstorg 53

111 27, Stockholm

+46 3 17 88 05 60

http://www.vicorepharma.com
address Vicore Pharma Holding AB

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+12.30% 12TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+12.15% 11TCr
BIONTECH SE Stock BioNTech SE
-8.14% 2.34TCr
ARGENX SE Stock argenx SE
-1.69% 2.18TCr
GENMAB A/S Stock Genmab A/S
-10.60% 1.81TCr
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.25% 1.67TCr
BEIGENE, LTD. Stock BeiGene, Ltd.
-15.33% 1.6TCr
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.80% 1.4TCr
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+28.03% 1.17TCr
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. VICO Stock
  4. Stock
  5. Company Vicore Pharma Holding AB